Critical Care of the Patient with Acute Stroke

Stroke: Pathophysiology, Diagnosis, and Management

Volumn , Issue , 2004, Pages 987-1024

  Georgiadis, Dimitrios ^a   Schwab, Stefan ^a   Hacke, Werner ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746895625     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-44-306600-0/50060-2     Document Type: Chapter

References (379)

1. von Kummer R, Meyding-Lamade U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994, 15:9-15.
2. von Kummer R, Holle R, Gizyska U, et al. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. AJNR Am J Neuroadiol 1996, 17:1743-1748.
3. Marks MP, Holmgren EB, Fox AJ, et al. Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke 1999, 30:389-392.
4. von Kummer R Effect of training in reading CT scans on patient selection for ECASS II. Neurology 1998, 51(Suppl 3):S50-S52.
5. von Kummer R, Allen KL, Holle R, et al. Acute stroke: Usefulness of early CT findings before thrombolytic therapy. Radiology 1997, 205:327-333.
6. von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001, 219:95-100.
7. Marks MP, Holmgren EB, Fox AJ, Patel S, et al. Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke 1999, 30:389-392.
8. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study. JAMA 1995, 274:1017-1025.
9. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998, 352:1245-1251.
10. Linfante I, Llinas RH, Caplan LR, Warach S MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke 1999, 30:2263-2267.
11. Schellinger PD, Jansen O, Fiebach JB, et al. A standardised MRI stroke protocol: Comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999, 30:765-768.
12. Noguchi K, Ogawa T, Seto H, et al. Subacute and chronic subarachnoid hemorrhage: Diagnosis with fluid-attenuated inversion-recovery MR imaging. Radiology 1997, 203:257-262.
13. Lansberg MG, Albers GW, Beaulieu C, Marks MP Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 2000, 54:1557-1561.
14. Albers GW, Landsberg MG, Norbash AM, et al. Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients. Neurology 2000, 54:1562-1567.
15. Warach S, Dashe JF, Edelmann RR Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: A preliminary analysis. J Cereb Blood Flow Metab 1996, 16:53-59.
16. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion-and-diffusion-weighted MRI. Neurology 1998, 51:418-426.
17. Jansen O, Schellinger PD, Fiebach JB, et al. Early recanalisation rates in acute ischemic stroke saves tissue at risk defined by MRI. Lancet 1999, 353:2036-2037.
18. Albers GW Expanding the window for thrombolytic therapy in acute stroke: The potential role of acute MRI for patient selection. Stroke 1999, 30:2230-2237.
19. Marks MP, Tong D, Beaulieu C, et al. Evaluation of early reperfusion and early IV rt-PA therapy using diffusion-and-perfusion-weighted MRI. Neurology 1999, 52:1792-1798.
20. Kidwell CS, Saver JL, Matiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462-469.
21. Ruggieri PM, Masaryk TJ, Ross JS, Modic MT Intracranial magnetic resonance imaging. Invest Radiol 1992, 27(Suppl 2):S33-S39.
22. Baron JC, Bousser MG, Comar D, et al. Non invasive tomographic study of cerebral blood flow and oxygen metabolism in vivo: Potentials, limitations and clinical applications in cerebral ischemic disorders. Eur Neurol 1981, 20:273-284.
23. Wise RJS, Bernardi S, Frackowiak RSJ, et al. Serial observations on the pathophysiology of acute stroke. Brain 1983, 106:197-222.
24. Marchal G, Benali K, Iglesias S, et al. Voxel-based mapping of irreversible ischemic damage with PET in acute stroke. Brain 1999, 123:2387-2400.
25. Furlan M, Marchal G, Viader F, et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996, 40:216-226.
26. Heiss WD, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: A positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998, 18:1298-1307.
27. Heiss WD, Thiel A, Grond M, Graf R Which targets are relevant for therapy of acute ischemic stroke?. Stroke 1999, 30:1486-1489.
28. Berrouschot J, Barthel H, Hesse S, et al. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD-SPECT. J Cereb Blood Flow Metab 1998, 18:921-929.
29. Berrouschot J, Barthel H, von Kummer R, et al. 99m technetiumethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998, 29:2556-2562.
30. Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000, 31:610-614.
31. Maurer M, Shambal S, Berg D, et al. Differentiation between intracerebral hemorrhage and ischemic stroke by transcranial color-coded duplex-sonography. Stroke 1998, 29:2563-2567.
32. Kaps M, Seidel G, Gerriets T, Traupe H Transcranial duplex monitoring discloses hemorrhagic complication following rt-PA thrombolysis. Acta Neurol Scand 1996, 93:61-63.
33. Gerriets T, Stolz E, Modrau B, et al. Sonographic monitoring of midline shift in hemispheric infarctions. Neurology 1999, 52:45-49.
34. Stolz E, Gerriets T, Fiss I, et al. Comparison of transcranial color-coded duplex sonography and cranial CT measurements for determining third ventricle midline shift in space-occupying stroke. AJNR Am J Neuroradiol 1999, 20:1567-1571.
35. Gerriets T, Stolz E, Konig S, et al. Sonographic monitoring of midline shift in space-occupying stroke: An early outcome predictor. Stroke 2001, 32:442-447.
36. Zeumer H, Hundgen R, Ferbert A, Ringelstein EB Local intraarterial fibrinolytic therapy in inaccessible internal carotid occlusion. Neuroradiology 1984, 26:315-317.
37. Zeumer H, Freitag HJ, Grzyska U, Neunzig HP Local intraarterial fibrinolysis in acute vertebrobasilar occlusion: Technical developments and recent results. Neuroradiology 1989, 31:336-340.
38. Hoffman AI, Lambiase RE, Haas RA, et al. Acute vertebrobasilar occlusion: Treatment with high-dose intraarterial urokinase. AJR Am J Roentgenol 1999, 172:709-712.
39. Higashida RT, Halbach VV, Dowd CF, et al. Intravascular balloon dilatation therapy for intracranial arterial vasospasm: Patient selection, technique, and clinical results. Neurosurg Rev 1992, 15:89-95.
40. Katoh H, Shima K, Shimizu A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 1999, 21:195-203.
41. Mayer SA, Copeland D, Bernardini GL, et al. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke 2000, 31:2346-2353.
42. Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: Indications, timing, and outcome. Neurology 1998, 51:447-451.
43. Grotta J, Pasteur W, Khwaja G, et al. Elective intubation for neurologic deterioration after stroke. Neurology 1995, 45:640-644.
44. Steiner T, Mendoza G, De Georgia M, et al. Prognosis of stroke patients requiring mechanical ventilation in a neurological critical care unit. Stroke 1997, 28:711-715.
45. Bushnell CD, Phillips-Bute BG, Laskowitz DT, et al. Survival and outcome after endotracheal intubation for acute stroke. Neurology 1999, 52:1374-1381.
46. Burtin P, Bollaert PE, Feldmann L, et al. Prognosis of stroke patients undergoing mechanical ventilation. Intensive Care Med 1994, 20:32-36.
47. Salord F, Gaussorgues P, Marti-Flich J, et al. Nosocomial maxillary sinusitis during mechanical ventilation: A prospective comparison of orotracheal versus the nasotracheal route for intubation. Intensive Care Med 1990, 16:390-393.
48. Holzapfel L, Chevret S, Madinier G, et al. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: Results of a prospective, randomized, clinical trial. Crit Care Med 1993, 21:1132-1138.
49. Georgiadis D, Schwarz S, Baumgartner RW, et al. Influence of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure in patients with acute stroke. Stroke 2001, 32:2088-2092.
50. Georgiadis D, Schwarz S, Baumgartner RW, Schwab S Influence of inspiration: expiration ratio on intracranial and cerebral perfusion pressure in patients with acute stroke. Intensive Care Med 2002, 28:1089-1093.
51. Whited RE A prospective study of laryngotracheal sequelae in long-term intubation. Laryngoscope 1984, 94:367-377.
52. Colice GL, Stukel TA, Dain B Laryngeal complications of prolonged intubation. Chest 1989, 96:877-884.
53. Dunham CM, LaMonica C Prolonged tracheal intubation in the trauma patient. J Trauma 1984, 24:120-124.
54. Qureshi AI, Suarez JI, Parekh PD, Bhardwaj A Prediction and timing of tracheostomy in patients with infratentorial lesions requiring mechanical ventilatory support. Crit Care Med 2000, 28:1383-1387.
55. Weinbroum AA, Halpern P, Rudick V, et al. Midazolam versus propofol for long-term sedation in the ICU: A randomized prospective comparison. Intensive Care Med 1997, 23:1258-1263.
56. Shafer A Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998, 26:947-956.
57. Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, et al. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs. Crit Care Med 1997, 25:33-40.
58. Chamorro C, de Latorre FJ, Montero A, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: Results of a prospective, randomized, multicenter trial. Crit Care Med 1996, 24:932-939.
59. Aitkenhead AR, Pepperman ML, Willatts SM, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989, 23(8665):704-709.
60. Stecker MM, Kramer TH, Raps EC, et al. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998, 39:18-26.
61. Prasad A, Worrall BB, Bertram EH, Bleck TP Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001, 42:380-386.
62. Bailey PL, Streisand JB, East KA, et al. Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg 1990, 70:8-15.
63. Werner C, Kochs E, Bause H, et al. Effects of sufentanil on cerebral hemodynamics and intracranial pressure in patients with brain injury. Anesthesiology 1995, 83:721-726.
64. Trindle MR, Dodson BA, Rampil IJ Effects of fentanyl versus sufentanil in equianesthetic doses on middle cerebral artery blood flow velocity. Anesthesiology 1993, 78:454-460.
65. Hanel F, Werner C, von Knobelsdorff G, Schulte am Esch J The effects of fentanyl and sufentanil on cerebral hemodynamics. J Neurosurg Anesthesiol 1997, 9:223-227.
66. Davalos A, Ricart W, Gonzalez-Huix F, et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996, 27:1028-1032.
67. Gariballa SE, Parker SG, Taub N, Castleden CM Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr 1998, 68:275-281.
68. Kistler JP, Vielma JD, Davis KR, et al. Effects of nitroglycerin on the diameter of intracranial and extracranial arteries in monkeys. Arch Neurol 1982, 39:631-634.
69. Rogers MC, Hamburger C, Owen K, Epstein MH Intracranial pressure in the cat during nitroglycerin-induced hypotension. Anesthesiology 1979, 51:227-229.
70. Cottrell JE, Gupta B, Rappaport H, Turndorf H, et al. Intracranial pressure during nitroglycerin-induced hypotension. J Neurosurg 1980, 53:309-311.
71. Robertson CS, Clifton GL, Taylor AA, Grossman RG Treatment of hypertension associated with head injury. J Neurosurg 1983, 59:455-460.
72. Skinhoj E, Overgaard J Effect of dihydralazine on intracranial pressure in patients with severe brain damage. Acta Med Scand Suppl 1983, 678:83-87.
73. Robertson CS, Clifton GL, Taylor AA, Grossman RG Treatment of hypertension associated with head injury. J Neurosurg 1983, 59:455-460.
74. Seifert V, Hussein S, Stolke D, et al. Modification of intracranial pressure by urapidil following experimental cold lesions in the cat. Anasthesiol Intensivther Notfallmed 1986, 21:218-222.
75. Puchstein C, Van Aken H, Anger C, Hidding J Influence of urapidil on intracranial pressure and intracranial compliance in dogs. Br J Anaesth 1983, 55:443-448.
76. Van Aken H, Puchstein C, Anger C, Lawin P The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension. Intensive Care Med 1983, 9:123-126.
77. Anger C, van Aken H, Feldhaus P, et al. Permeation of the blood-brain barrier by urapidil and its influence on intracranial pressure in man in the presence of compromised intracranial dynamics. J Hypertens Suppl 1988, 6:S63-S64.
78. Bernard JM, Ottmar K, Bonnet F Comparison of intravenous and epidural clonidine for postoperative patient-controlled analgesia. Anesth Analg 1995, 81:706-712.
79. Hall JE, Uhrich TD, Ebert TJ Sedative, analgesic and cognitive effects of clonidine infusions in humans. Br J Anaesth 2001, 86:5-11.
80. Greene CS, Gretler DD, Cervenka K, et al. Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine. Am J Emerg Med 1990, 8:293-296.
81. Asgeirsson B, Grande PO, Nordstrom CH, et al. Effects of hypotensive treatment with alpha 2-agonist and beta 1-antagonist on cerebral haemodynamics in severely head injured patients. Acta Anaesthesiol Scand 1995, 39:347-351.
82. Kanawati IS, Yaksh TL, Anderson RE, Marsh RW Effects of clonidine on cerebral blood flow and the response to arterial CO2. J Cereb Blood Flow Metab 1986, 6:358-365.
83. Favre JB, Gardaz JP, Ravussin P Effect of clonidine on ICP and on the hemodynamic responses to nociceptive stimuli in patients with brain tumors. J Neurosurg Anesthesiol 1995, 7:159-167.
84. ter Minassian A, Beydon L, Decq P, Bonnet F Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg 1997, 84:127-132.
85. Maekawa T, Cho S, Fukusaki M, et al. Effects of clonidine on human middle cerebral artery flow velocity and cerebrovascular CO2 response during sevoflurane anesthesia. J Neurosurg Anesthesiol 1999, 11:173-177.
86. Lee HW, Caldwell JE, Dodson B, et al. The effect of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity, and response to increased arterial pressure in human volunteers. Anesthesiology 1997, 87:553-558.
87. Feibel JH, Baldwin CA, Joynt RJ Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: Control with propranolol. Ann Neurol 1981, 9:340-343.
88. Globus M, Keren A, Eldad M, et al. The effect of chronic propranolol therapy on regional cerebral blood flow in hypertensive patients. Stroke 1983, 14:964-967.
89. Van Aken H, Puchstein C, Schweppe ML, Heinecke A Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension. Acta Anaesthesiol Scand 1982, 26:615-619.
90. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med 1999, 27:965-971.
91. Griffith DN, James IM, Newbury PA, Woollard ML The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br J Clin Pharmacol 1979, 7:491-494.
92. Orlowski JP, Shiesley D, Vidt DG, et al. Labetalol to control blood pressure after cerebrovascular surgery. Crit Care Med 1988, 16:765-768.
93. Griffin JP, Cottrell JE, Hartung J, Shwiry B Intracranial pressure during nifedipine-induced hypotension. Anesth Analg 1983, 62:1078-1080.
94. Anger C, Wusten R, Woulters P, et al. The behavior of intracranial pressure and intracranial compliance in nifedipine-induced hypotension. Anasthesiol Intensivther Notfallmed 1988, 23:303-308.
95. Wusten R, Hemelrijck J, Mattheussen M, et al. Effect of nifedipine and urapidil on autoregulation of cerebral circulation in the presence of an intracranial space occupying lesion. Anasthesiol Intensivther Notfallmed 1990, 25:140-145.
96. Bertel O, Conen D, Radu EW, et al. Nifedipine in hypertensive emergencies. BMJ 1983, 286(6358):19-21.
97. Tateishi A, Sano T, Takeshita H, et al. Effects of nifedipine on intracranial pressure in neurosurgical patients with arterial hypertension. J Neurosurg 1988, 69:213-215.
98. Sakabe T, Nagai I, Ishikawa T, et al. Nicardipine increases cerebral blood flow but does not improve neurologic recovery in a canine model of complete cerebral ischemia. J Cereb Blood Flow Metab 1986, 6:684-690.
99. Kittaka M, Giannotta SL, Zelman V, et al. Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg 1997, 87:731-737.
100. Tanaka M, Yoshida Y, Mitomi A, et al. Effects of calcium antagonists, felodipine and nicardipine, on cerebral circulation in dogs. Jpn J Pharmacol 1990, 52:273-279.
101. Gaab MR, Czech T, Korn A Intracranial effects of nicardipine. Br J Clin Pharmacol 1985, 20(Suppl 1):67S-74S.
102. Akopov SE, Simonian NA, Kazarian AV Effects of nifedipine and nicardipine on regional cerebral blood flow distribution in patients with arterial hypertension. Methods Find Exp Clin Pharmacol 1996, 18:685-692.
103. Abe K, Iwanaga H, Inada E Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth 1994, 6:99-105.
104. Lisk DR, Grotta JC, Lamki LM, et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993, 50:855-862.
105. Nishikawa T, Omote K, Namiki A, Takahashi T The effects of nicardipine on cerebrospinal fluid pressure in humans. Anesth Analg 1986, 65:507-510.
106. Frei A, Muller-Brand J Cerebral blood flow and antihypertensive treatment with enalapril. J Hypertens 1986, 4:365-367.
107. Fagan SC, Robert S, Ewing JR, et al. Cerebral blood flow changes with enalapril. Pharmacotherapy 1992, 12:319-323.
108. Patel RV, Ramadan NM, Levine SR, et al. Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive disease. J Cardiovasc Pharmacol 1996, 28:48-52.
109. Kobayashi S, Yamaguchi S, Okada K, et al. The effect of enalapril maleate on cerebral blood flow in chronic cerebral infarction. Angiology 1992, 43:378-388.
110. Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections: A prospective epidemiologic study. N Engl J Med 1984, 310:553-555.
111. Stenager E, Gerner-Smidt P, Kock-Jensen C Ventriculostomy-related infections-an epidemiological study. Acta Neurochir (Wien) 1986, 83:20-23.
112. Clark WC, Muhlbauer MS, Lowrey R, et al. Complications of intracranial pressure monitoring in trauma patients. Neurosurgery 1989, 25:20-24.
113. Aucoin PJ, Kotilainen HR, Gantz NM, et al. Intracranial pressure monitors: Epidemiologic study of risk factors and infections. Am J Med 1986, 80:369-376.
114. Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: The effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 1996, 85:419-424.
115. Wyler AR, Kelly WA Use of antibiotics with external ventriculostomies. J Neurosurg 1972, 37:185-187.
116. Rosner MJ, Becker DP ICP monitoring: Complications and associated factors. Clin Neurosurg 1976, 23:494-519.
117. Prabhu VC, Kaufman HH, Voelker JL, et al. Prophylactic antibiotics with intracranial pressure monitors and external ventricular drains: A review of the evidence. Surg Neurol 1999, 52:226-236.
118. Friedman WA, Vries JK Percutaneous tunnel ventriculostomy: Summary of 100 procedures. J Neurosurg 1980, 53:662-665.
119. Khanna RK, Rosenblum ML, Rock JP, Malik GM Prolonged external ventricular drainage with percutaneous long-tunnel ventriculostomies. J Neurosurg 1995, 83:791-794.
120. Vries JK, Becker DP, Young HF A subarachnoid screw for monitoring intracranial pressure: Technical note. J Neurosurg 1973, 39:416-419.
121. Winn HR, Dacey RG, Jane JA Intracranial subarachnoid pressure recording: Experience with 650 patients. Surg Neurol 1977, 8:41-47.
122. Mendelow AD, Rowan JO, Murray L, Kerr AE A clinical comparison of subdural screw pressure measurements with ventricular pressure. J Neurosurg 1983, 58:45-50.
123. Dearden NM, McDowall DG, Gibson RM Assessment of Leeds device for monitoring intracranial pressure. J Neurosurg 1984, 60:123-129.
124. Kosteljanetz M, Borgesen SE, Stjernholm P, et al. Clinical evaluation of a simple epidural pressure sensor. Acta Neurochir (Wien) 1986, 83:108-111.
125. Bruder N, N'Zoghe P, Graziani N, et al. A comparison of extradural and intraparenchymatous intracranial pressures in head injured patients. Intensive Care Med 1995, 21:850-852.
126. Gambardella G, d'Avella D, Tomasello F Monitoring of brain tissue pressure with a fiberoptic device. Neurosurgery 1992, 31:918-921.
127. Shapiro S, Bowman R, Callahan J, Wolfla C The fiberoptic intraparenchymal cerebral pressure monitor in 244 patients. Surg Neurol 1996, 45:278-282.
128. Munch E, Weigel R, Schmiedek P, Schurer L The Camino intracranial pressure device in clinical practice: Reliability, handling characteristics and complications. Acta Neurochir (Wien) 1998, 140:1113-1119.
129. Khan SH, Kureshi IU, Mulgrew T, et al. Comparison of percutaneous ventriculostomies and intraparenchymal monitor: A retrospective evaluation of 156 patients. Acta Neurochir Suppl (Wien) 1998, 71:50-52.
130. Crutchfield JS, Narayan RK, Robertson CS, Michael LH Evaluation of a fiberoptic intracranial pressure monitor. J Neurosurg 1990, 72:482-487.
131. Bavetta S, Norris JS, Wyatt M, et al. Prospective study of zero drift in fiberoptic pressure monitors used in clinical practice. J Neurosurg 1997, 86:927-930.
132. Czosnyka M, Czosnyka Z, Pickard JD Laboratory testing of three intracranial pressure microtransducers: Technical report. Neurosurgery 1996, 38:219-224.
133. Czosnyka M, Czosnyka Z, Pickard JD Laboratory testing of the Spiegelberg brain pressure monitor: A technical report. J Neurol Neurosurg Psychiatry 1997, 63:732-735.
134. The Brain Trauma Foundation The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Recommendations for intracranial pressure monitoring technology. J Neurotrauma 2000, 17:497-506.
135. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581-1587.
136. Hacke W, Brott T, Caplan L, et al. Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience. Neurology 1999, 53(Suppl 4):S3-S14.
137. Wardlaw JM, del Zoppo G, Yamaguchi T Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2000, CD000213.
138. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003-2011.
139. Ropper AH, O'Rourke D, Kennedy SK Head position, intracranial pressure, and compliance. Neurology 1982, 32:1288-1291.
140. Rosner MJ, Coley IB Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg 1986, 65:636-641.
141. Feldman Z, Kanter MJ, Robertson CS, et al. Effect of head elevation on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in head-injured patients. J Neurosurg 1992, 76:207-211.
142. Meixensberger J, Baunach S, Amschler J, et al. Influence of body position on tissue-PO2, cerebral perfusion pressure and intracranial pressure in patients with acute brain injury. Neurol Res 1997, 19:249-253.
143. Moraine JJ, Berre J, Melot C Is cerebral perfusion pressure a major determinant of cerebral blood flow during head elevation in comatose patients with severe intracranial lesions?. J Neurosurg 2000, 92:606-614.
144. Schwarz S, Georgiadis D, Aschoff A, Schwab S Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 2002, 33:497-501.
145. Kaufmann AM, Cardoso ER Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992, 77:584-589.
146. Garcia-Sola R, Pulido P, Capilla P The immediate and long-term effects of mannitol and glycerol: A comparative experimental study. Acta Neurochir (Wien) 1991, 109:114-121.
147. Marshall LF, Smith RW, Rauscher LA, Shapiro HM Mannitol dose requirements in brain-injured patients. J Neurosurg 1978, 48:169-172.
148. James HE Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien) 1980, 51:161-172.
149. McGraw CP, Howard G Effect of mannitol on increased intracranial pressure. Neurosurgery 1983, 13:269-271.
150. Muizelaar JP, Lutz HA, Becker DP Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984, 61:700-706.
151. Mendelow AD, Teasdale GM, Russell T, et al. Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985, 63:43-48.
152. Kirkpatrick PJ, Smielewski P, Piechnik S, et al. Early effects of mannitol in patients with head injuries assessed using bedside multimodality monitoring. Neurosurgery 1996, 39:714-720.
153. Pollay M, Fullenwider C, Roberts PA, Stevens FA Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983, 59:945-950.
154. Biestro A, Alberti R, Galli R, et al. Osmotherapy for increased intracranial pressure: Comparison between mannitol and glycerol. Acta Neurochir (Wien) 1997, 139:725-732.
155. Node Y, Nakazawa S Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. Adv Neurol 1990, 52:359-363.
156. Bereczki D, Liu M, do Prado GF, Fekete I Mannitol for acute stroke. Cochrane Database Syst Rev 2001, CD001153.
157. Gunnar W, Jonasson O, Merlotti G, et al. Head injury and hemorrhagic shock: Studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery 1988, 103:398-407.
158. Fisher B, Thomas D, Peterson B Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol 1992, 4:4-10.
159. Gemma M, Cozzi S, Piccoli S, et al. Hypertonic saline fluid therapy following brain stem trauma. J Neurosurg Anesthesiol 1996, 8:137-141.
160. Hartl R, Ghajar J, Hochleuthner H, et al. Hypertonic/hyperoncotic saline reliably reduces ICP in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl (Wien) 1997, 70:126-129.
161. Khanna S, Davis D, Peterson B, et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000, 28:1144-1151.
162. Gemma M, Cozzi S, Tommasino C, et al. 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 1997, 9:329-334.
163. Schwarz S, Schwab S, Bertram M, et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998, 29:1550-1555.
164. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998, 26:440-446.
165. Schwarz S, Georgiadis D, Aschoff A, Schwab S Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002, 33:136-140.
166. Gaab MR, Seegers K, Smedema RJ, et al. A comparative analysis of THAM (Tris-buffer) in traumatic brain oedema. Acta Neurochir Suppl (Wien) 1990, 51:320-323.
167. Wolf AL, Levi L, Marmarou A, et al. Effect of THAM upon outcome in severe head injury: A randomized prospective clinical trial. J Neurosurg 1993, 78:54-59.
168. Michenfelder JD, Milde JH Failure of prolonged hypocapnia, hypothermia, or hypertension to favorably alter acute stroke in primates. Stroke 1977, 8:87-91.
169. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial. J Neurosurg 1991, 75:731-739.
170. Olsen RW GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 1981, 37:1-13.
171. Woodcock J, Ropper AH, Kennedy SK High dose barbiturates in non-traumatic brain swelling: ICP reduction and effect on outcome. Stroke 1982, 13:785-787.
172. Lee MW, Deppe SA, Sipperly ME, et al. The efficacy of barbiturate coma in the management of uncontrolled intracranial hypertension following neurosurgical trauma. J Neurotrauma 1994, 11:325-331.
173. Schwab S, Spranger M, Schwarz S, Hacke W Barbiturate coma in severe hemispheric stroke: Useful or obsolete?. Neurology 1997, 48:1608-1613.
174. Cormio M, Gopinath SP, Valadka A, Robertson CS Cerebral hemodynamic effects of pentobarbital coma in head-injured patients. J Neurotrauma 1999, 16:927-936.
175. Schwartz ML, Tator CH, Rowed DW, et al. The University of Toronto head injury treatment study: A prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984, 11:434-440.
176. Qizilbach N, Lewington SL, Lopez-Arrieta JM Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2002, CD000064.
177. Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987, 316:1229-1233.
178. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: A prospective multicenter study. Arch Neurol 2000, 57:1617-1622.
179. Meierkord H, Wieshmann U, Niehaus L, Lehmann R Structural consequences of status epilepticus demonstrated with serial magnetic resonance imaging. Acta Neurol Scand 1997, 96:127-132.
180. Mellema LM, Koblik PD, Kortz GD, et al. Reversible magnetic resonance imaging abnormalities in dogs following seizures. Vet Radiol Ultrasound 1999, 40:588-595.
181. Hisano T, Ohno M, Egawa T, et al. Changes in diffusion-weighted MRI after status epilepticus. Pediatr Neurol 2000, 22:327-329.
182. Kim JA, Chung JI, Yoon PH, et al. Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: Peri-ictal diffusion-weighted imaging. AJNR Am J Neuroradiol 2001, 22:1149-1160.
183. Cushing H The establishment of cerebral hernia as a decompressive measure for inaccessible brain tumors: With the description of intermuscular methods of making the bone defect in temporal and occipital regions. Surg Gynecol Obstet 1905, 1:297-314.
184. Doerfler A, Forsting M, Reith W, et al. Decompressive craniectomy in a rat model of "malignant" cerebral hemispheric stroke: Experimental support for an aggressive therapeutic approach. J Neurosurg 1996, 85:853-859.
185. Forsting M, Reith W, Schabitz WR, et al. Decompressive craniectomy for cerebral infarction: An experimental study in rats. Stroke 1995, 26:259-264.
186. Engelhorn T, von Kummer R, Reith W, et al. What is effective in malignant middle cerebral artery infarction: Reperfusion, craniectomy, or both? An experimental study in rats. Stroke 2002, 33:617-622.
187. Colbourne F, Corbett D, Zhao Z, et al. Prolonged but delayed postischemic hypothermia: A long-term outcome study in the rat middle cerebral artery occlusion model. J Cereb Blood Flow Metab 2000, 20:1702-1708.
188. Corbett D, Hamilton M, Colbourne F Persistent neuroprotection with prolonged postischemic hypothermia in adult rats subjected to transient middle cerebral artery occlusion. Exp Neurol 2000, 163:200-206.
189. Huh PW, Belayev L, Zhao W, et al. Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia. J Neurosurg 2000, 92:91-99.
190. Winfree CJ, Baker CJ, Connolly ES, et al. Mild hypothermia reduces penumbral glutamate levels in the rat permanent focal cerebral ischemia model. Neurosurgery 1996, 38:1216-1222.
191. Nakashima K, Todd MM Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization. Stroke 1996, 27:913-918.
192. Busto R, Globus MY, Dietrich WD, et al. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 1989, 20:904-910.
193. Karibe H, Zarow GJ, Graham SH, Weinstein PR Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1994, 14:620-627.
194. Dietrich WD, Busto R, Halley M, Valdes I The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J Neuropathol Exp Neurol 1990, 49:486-497.
195. Gartshore G, Patterson J, Macrae IM Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol 1997, 147:353-360.
196. Krafft P, Frietsch T, Lenz C, et al. Mild and moderate hypothermia (alpha-stat) do not impair the coupling between local cerebral blood flow and metabolism in rats. Stroke 2000, 31:1393-1400.
197. Clifton GL, Allen S, Barrodale P, et al. A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993, 10:263-271.
198. Marion DW, Obrist WD, Carlier PM, et al. The use of moderate therapeutic hypothermia for patients with severe head injuries: A preliminary report. J Neurosurg 1993, 79:354-362.
199. Clifton GL, Miller ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001, 344:556-563.
200. Hacke W, Schwab S, Horn M, et al. 'Malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol 1996, 53:309-315.
201. Berrouschot J, Sterker M, Bettin S, et al. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med 1998, 24:620-623.
202. Schwab S, Aschoff A, Spranger M, et al. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996, 47:393-398.
203. Hacke W, Schwab S, De Georgia M Intensive care of acute ischemic stroke. Cerebrovasc Dis 1994, 4:385-392.
204. Kondziolka D, Fazl M Functional recovery after decompressive craniectomy for cerebral infarction. Neurosurgery 1988, 23:143-147.
205. Delashaw JB, Broaddus WC, Kassell NF, et al. Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 1990, 21:874-881.
206. Jourdan C, Convert J, Mottolese C, et al. Evaluation of the clinical benefit of decompression hemicraniectomy in intracranial hypertension not controlled by medical treatment. Neurochirurgie 1993, 39:304-310.
207. Kalia KK, Yonas H An aggressive approach to massive middle cerebral artery infarction. Arch Neurol 1993, 50:1293-1297.
208. Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 1997, 40:1168-1175.
209. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998, 29:1888-1893.
210. Holtkamp M, Buchheim K, Unterberg A, et al. Hemicraniectomy in elderly patients with space occupying media infarction: Improved survival but poor functional outcome. J Neurol Neurosurg Psychiatry 2001, 70:226-228.
211. Mori K, Aoki A, Yamamoto T, Maeda M Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling. Acta Neurochir (Wien) 2001, 143:483-492.
212. Schwab S, Schwarz S, Spranger M, et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998, 29:2461-2466.
213. Schwab S, Georgiadis D, Berrouschot J, et al. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001, 32:2033-2035.
214. Krieger DW, De Georgia MA, Abou-Chebl A, et al. Cooling for acute ischemic brain damage (cool aid): An open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001, 32:1847-1854.
215. Georgiadis D, Schwarz S, Kollmar R, Schwab S Endovascular cooling for moderate hypothermia in patients with acute stroke: First results of a novel approach. Stroke 2001, 32:2550-2553.
216. Georgiadis D, Schwarz S, Aschoff A, Schwab S Hemicraniectomy and moderate hypothermia in patients with severe hemispheric stroke. Stroke 2002, 33:1584-1588.
217. Lisk DR, Grotta JC, Lamki LM, et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993, 50:855-862.
218. Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council, American Heart Association. Stroke 2003, 34:1056-1083.
219. Hacke W, Kaste M, Skyhöj Olsen T, et al. European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee. Eur J Neurol 2000, 7:607-623.
220. Rordorf G, Koroshetz WJ, Ezzeddine MA, et al. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001, 56:1210-1213.
221. Schwarz S, Georgiadis D, Aschoff A, Schwab S Effect of induced hypertension on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 2002, 33:998-1004.
222. Archer CR, Horenstein S Basilar artery occlusion: Clinical and radiological correlation. Stroke 1977, 8:383-390.
223. Castaigne P, Lhermitte F, Gautier JC, et al. Arterial occlusions in the vertebro-basilar system: A study of 44 patients with postmortem data. Brain 1973, 96:133-154.
224. Cravioto H, Rey-Bellet J, Prose PH, Feigin I Occlusion of the basilar artery: A clinical and pathologic study of 14 autopsied cases. Neurology 1958, 8:145-152.
225. Fields WS, Ratinov G, Wiebel J, Campos RJ Survival following basilar artery occlusion. Arch Neurol 1966, 15:463-471.
226. Kubik CS, Adams RD Occlusion of the basilar artery: A clinical and pathological study. Brain 1946, 69:73-121.
227. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216-1222.
228. Brandt T, von Kummer R, Muller-Kuppers M, Hacke W Thrombolytic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome. Stroke 1996, 27:875-881.
229. Cross DT, Moran CJ, Akins PT, et al. Collateral circulation and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol 1998, 19:1557-1563.
230. Cross DT, Moran CJ, Akins PT, et al. Relationship of clot location and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol 1997, 18:1221-1228.
231. Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intraarterial thrombolytic therapy: A meta-analytical approach. Neurosurgery 1999, 45:539-545.
232. Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: Urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 1993, 35:159-162.
233. Cross DT, Derdeyn CP, Moran CJ Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator. AJNR Am J Neuroradiol 2001, 22:521-525.
234. Horowitz MB, Pride GL, Graybeal DF, Purdy PD Percutaneous transluminal angioplasty and stenting of midbasilar stenoses: Three technical case reports and literature review. Neurosurgery 1999, 45:925-930.
235. Phatouros CC, Higashida RT, Malek AM, et al. Endovascular stenting of an acutely thrombosed basilar artery: Technical case report and review of the literature. Neurosurgery 1999, 44:667-673.
236. Junghans U, Seitz RJ, Wittsack HJ, et al. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: Report of four cases. Radiology 2001, 221:795-801.
237. Rieke K, Krieger D, Adams HP, et al. Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuroradiological and neurophysiological data. Cerebrovasc Dis 1993, 3:45-55.
238. Heros RC Surgical treatment of cerebellar infarction. Stroke 1992, 23:937-938.
239. Chen HJ, Lee TC, Wei CP Treatment of cerebellar infarction by decompressive suboccipital craniectomy. Stroke 1992, 23:957-961.
240. Chen ST, Chen SD, Hsu CY, Hogan EL Progression of hypertensive intracerebral hemorrhage. Neurology 1989, 39:1509-1514.
241. Schwarz S, Häffner K, Aschoff A, Schwab S Incidence and prognostic significance of fever following spontaneous supratentorial intracerebral hemorrhage. Neurology 2000, 54:354-361.
242. Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996, 94:1167-1174.
243. Wijman CA, Kase SK What should become the treatment of cerebral hemorrhage. Acute Stroke Treatment 1997, 245-258. Martin Dunitz. J. Bogousslavsky (Ed.).
244. Fredericksson K, Norrving B, Strömblad L Emergency reversal of anticoagulation. Stroke 1992, 23:972-977.
245. Wijdicks EFM, Schievink WI, Brown RD, Mullany CJ The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 1998, 42:769-773.
246. Phan TG, Koh M, Wijdicks EF Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000, 57:1710-1713.
247. Bertram M, Bonsanto M, Hacke W, Schwab S Managing the therapeutic dilemma: Patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol 2000, 247:209-214.
248. Phan TG, Koh M, Vierkant RA, Wijdicks EF Hydrocephalus is a determinant of early mortality in putaminal hemorrhage. Stroke 2000, 31:2157-2162.
249. Caplan LR General symptoms and signs. Kaplan Intracerebral Hemorrhage 1994, 31-43. Butterworth-Heinemann, Boston. C.S. Kase (Ed.).
250. Massaro AR, Sacco RL, Mohr JP, et al. Clinical discriminators of lobar and deep hemorrhages: The Stroke Data Bank. Neurology 1991, 41:1881-1885.
251. McKissok W, Richardson A, Taylor J Primary intracerebral hemorrhage: A controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961, 2:221-226.
252. Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intra-cerebral hemorrhage: A prospective randomized trial of surgical and conservative treatment. J Neurosurg 1990, 72:152-155.
253. Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: A randomized study. J Neurosurg 1989, 70:530-535.
254. Batjer HH, Reisch JS, Allen BC, et al. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage: A prospective randomized controlled trial. Arch Neurol 1990, 47:1103-1106.
255. Morgenstern MD, Frankowski RF, Shedden P, et al. Surgical treatment for intracerebral hemorrhage (STICH): A single-center, randomized clinical trial. Neurology 1998, 51:1359-1363.
256. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: A randomized feasibility study. Stroke 1999, 30:1833-1839.
257. Backlund E-O, Holst H Controlled subtotal evacuation of intracerebral hematomas by stereotactic technique. Surg Neurol 1978, 9:99-101.
258. Matsumoto K, Hondo H CT-guided stereotaxic evacuation of hypertensive intracerebral hematomas. J Neurosurg 1984, 61:440-448.
259. Niizuma H, Otzuki T, Juhkura H, et al. CT-guided stereotactic aspiration of intracerebral hematoma: Result of hematolysis method using urokinase. Appl Neurophysiol 1985, 48:427-430.
260. Schaller C, Rohde V, Meyer B, Hassler W Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue plasminogen activator. Neurosurgery 1995, 36:328-335.
261. Ott KH, Kase CS, Ojemann RG, Mohr JP Cerebellar hemorrhage: Diagnosis and treatment: A review of 56 cases. Arch Neurol 1974, 31:160-167.
262. Kassell NF, Torner JC, Jane JA, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 1990, 73:37-47.
263. Hop JW, Rinkel GJ, Algra A, van Gijn J Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke 1998, 29:798-804.
264. Kassell NF, Torner JC, Haley EC, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990, 73:18-36.
265. Hutter BO, Kreitschmann-Andermahr I, Gilsbach JM Cognitive deficits in the acute stage after subarachnoid hemorrhage. Neurosurgery 1998, 43:1054-1065.
266. Hart RG, Byer JA, Slaughter JR, et al. Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery 1981, 8:417-421.
267. Bassi P, Bandera R, Loiero M, et al. Warning signs in subarachnoid hemorrhage: A cooperative study. Acta Neurol Scand 1991, 84:277-281.
268. Hunt WE, Hess RM Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968, 28:14-20.
269. van der Wee N, Rinkel GJ, Hasan D, van Gijn J Detection of subarachnoid haemorrhage on early CT: Is lumbar puncture still needed after a negative scan?. J Neurol Neurosurg Psychiatry 1995, 58:357-359.
270. van Gijn J, van Dongen KJ The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology 1982, 23:153-156.
271. Mitchell P, Wilkinson ID, Hoggard N, et al. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2001, 70:205-211.
272. Noguchi K, Seto H, Kamisaki Y, et al. Comparison of fluid-attenuated inversion-recovery MR imaging with CT in a simulated model of acute subarachnoid hemorrhage. AJNR Am J Neuroradiol 2000, 21:923-927.
273. van Gijn J, Rinkel GJ Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 2001, 124:249-278.
274. Velthuis BK, Rinkel GJ, Ramos LM, et al. Perimesencephalic hemorrhage: Exclusion of vertebrobasilar aneurysms with CT angiography. Stroke 1999, 30:1103-1109.
275. Ruigrok YM, Rinkel GJ, Buskens E, et al. Perimesencephalic hemorrhage and CT angiography: A decision analysis. Stroke 2000, 31:2976-2983.
276. Kassell NF, Torner JC Aneurysmal rebleeding: A preliminary report from the Cooperative Aneurysm Study. Neurosurgery 1983, 13:479-481.
277. Fujii Y, Takeuchi S, Sasaki O, et al. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 1996, 84:35-42.
278. Biller J, Godersky JC, Adams HP Management of aneurysmal subarachnoid hemorrhage. Stroke 1988, 19:1300-1305.
279. Torner JC, Kassell NF, Wallace RB, Adams HP Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: Report of the Cooperative Aneurysm Study. Neurosurgery 1981, 9:506-513.
280. Ojemann RG Management of the unruptured intracranial aneurysm. N Engl J Med 1981, 304:725-726.
281. Vermeulen M, Lindsay KW, Murray GD, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 1984, 311:432-437.
282. Kassell NF, Torner JC, Adams HP Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage: Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 1984, 61:225-230.
283. Roos Y Antifibrinolytic treatment in subarachnoid hemorrhage: A randomized placebo-controlled trial. STAR Study Group. Neurology 2000, 54:77-82.
284. Glick R, Green D, Ts'ao C, et al. High dose epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Neurosurgery 1981, 9:398-401.
285. Solomon RA, Fink ME Current strategies for the management of aneurysmal subarachnoid hemorrhage. Arch Neurol 1987, 44:769-774.
286. van Gijn J, Hijdra A, Wijdicks EF, et al. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 1985, 63:355-362.
287. Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 1990, 72:559-566.
288. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: A systematic review of the literature. J Neurol 2000, 247:117-121.
289. Gruber A, Reinprecht A, Bavinzski G, et al. Chronic shunt-dependent hydrocephalus after early surgical and early endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 1999, 44:503-509.
290. Kosteljanetz M CSF dynamics in patients with subarachnoid and/or intraventricular hemorrhage. J Neurosurg 1984, 60:940-946.
291. Rebuck JA, Murry KR, Rhoney DH, et al. Infection related to intracranial pressure monitors in adults: Analysis of risk factors and antibiotic prophylaxis. J Neurol Neurosurg Psychiatry 2000, 69:381-384.
292. Paramore CG, Turner DA Relative risks of ventriculostomy infection and morbidity. Acta Neurochir (Wien) 1994, 127:79-84.
293. Treggiari-Venzi MM, Suter PM, Romand JA Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 2001, 48:249-261.
294. Shimoda M, Oda S, Tsugane R, Sato O Prognostic factors in delayed ischaemic deficit with vasospasm in patients undergoing early aneurysm surgery. Br J Neurosurg 1997, 11:210-215.
295. Wilkins RH Cerebral vasospasm. Crit Rev Neurobiol 1990, 6:51-77.
296. Heros RC, Zervas NT, Varsos V Cerebral vasospasm after subarachnoid hemorrhage: An update. Ann Neurol 1983, 14:599-608.
297. Vora YY, Suarez-Almazor M, Steinke DE, et al. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1999, 44:1237-1247.
298. Laumer R, Steinmeier R, Gonner F, et al. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1: Reliability of flow velocities in clinical management. Neurosurgery 1993, 33:1-8.
299. Steinmeier R, Laumer R, Bondar I, et al. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 2: Pulsatility indices: Normal reference values and characteristics in subarachnoid hemorrhage. Neurosurgery 1993, 33:10-18.
300. Origitano TC, Wascher TM, Reichman OH, Anderson DE Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 1990, 27:729-739.
301. Kassell NF, Peerless SJ, Durward QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982, 11:337-343.
302. Germano A, d'Avella D, Imperatore C, et al. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000, 142:575-580.
303. Wood JH, Kee DB Hemorrheology of the cerebral circulation in stroke. Stroke 1985, 16:765-772.
304. Awad IA, Carter LP, Spetzler RF, et al. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 1987, 18:365-372.
305. Wijdicks EFM New management trends in aneurysmal subarachnoid hemorrhage. Acute Stroke Treatment 1997, 259-269. Martin Dunitz. J. Bogousslavsky (Ed.).
306. Solomon RA, Fink ME, Lennihan L Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery: Results of a preliminary trial. Arch Neurol 1988, 45:325-332.
307. Shimoda M, Oda S, Tsugane R, Sato O Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 1993, 78:423-429.
308. Buckland MR, Batjer HH, Giesecke AH Anesthesia for cerebral aneurysm surgery: Use of induced hypertension in patients with symptomatic vasospasm. Anesthesiology 1988, 69:116-119.
309. Hasan D, Wijdicks EF, Vermeulen M Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 1990, 27:106-108.
310. Siesjo BK Cellular calcium metabolism, seizures, and ischemia. Mayo Clin Proc 1986, 61:299-302.
311. Hongo K, Kobayashi S Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage. Neurol Res 1993, 15:218-224.
312. Barker FG, Ogilvy CS Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta-analysis. J Neurosurg 1996, 84:405-414.
313. Feigin VL, Rinkel GJ, Algra A, et al: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD000277, 2000.
314. Kassell NF, Haley EC, Apperson-Hansen C, Alves WM Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 1996, 84:221-228.
315. Haley EC, Kassell NF, Apperson-Hansen C, et al. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 1997, 86:467-474.
316. Lanzino G, Kassell NF, Dorsch NW, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I: A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 1999, 90:1011-1017.
317. Hop JW, Rinkel GJ, Algra A, et al. Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 2000, 54:872-888.
318. Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998, 88:277-284.
319. Clouston JE, Numaguchi Y, Zoarski GH, et al. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 1995, 16:27-38.
320. Tsurushima H, Hyodo A, Yoshii Y Papaverine and vasospasm. J Neurosurg 2000, 92:509-511.
321. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992, 77:842-847.
322. Barr JD, Mathis JM, Horton JA Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 1994, 15:719-723.
323. Carhuapoma JR, Qureshi AI, Tamargo RJ, et al. Intra-arterial papaverine-induced seizures: Case report and review of the literature. Surg Neurol 2001, 56:159-163.
324. Kassell NF, Helm G, Simmons N, et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992, 77:848-852.
325. Newell DW, Eskridge J, Mayberg M, et al. Endovascular treatment of intracranial aneurysms and cerebral vasospasm. Clin Neurosurg 1992, 39:348-360.
326. Higashida RT, Halbach VV, Cahan LD, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989, 71(Pt 1):648-653.
327. Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 1998, 42:510-516.
328. Bejjani GK, Bank WO, Olan WJ, Sekhar LN The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998, 42:979-986.
329. Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000, 92:284-290.
330. Findlay JM, Weir BK, Kassell NF, et al. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991, 75:181-188.
331. Rohde V, Schaller C, Hassler WE Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 1995, 58:447-451.
332. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: A systematic review of the literature. J Neurol 2000, 247:117-121.
333. Mayfrank L, Hutter BO, Kohorst Y, et al. Influence of intraventricular hemorrhage on outcome after rupture of intracranial aneurysm. Neurosurg Rev 2001, 24:185-191.
334. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase effects on 30-day survival. Stroke 2000, 31:841-847.
335. Minegishi A, Ishizaki T, Yoshida Y, et al. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage: Clinical implications. Arch Neurol 1987, 44:423-428.
336. Staub F, Graf R, Gabel P, et al. Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage. Neurosurgery 2000, 47:1106-1115.
337. Wijdicks EF, Vermeulen M, van Gijn J Hyponatraemia and volume status in aneurysmal subarachnoid haemorrhage. Acta Neurochir Suppl (Wien) 1990, 47:111-113.
338. Disney L, Weir B, Grace M, Roberts P Trends in blood pressure, osmolality and electrolytes after subarachnoid hemorrhage from aneurysms. Can J Neurol Sci 1989, 16:299-304.
339. Kurokawa Y, Uede T, Ishiguro M, et al. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol 1996, 46:500-507.
340. Diringer M, Ladenson PW, Stern BJ, et al. Plasma atrial natriuretic factor and subarachnoid hemorrhage. Stroke 1988, 19:1119-1124.
341. Nelson PB, Seif SM, Maroon JC, Robinson AG Hyponatremia in intracranial disease: Perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg 1981, 55:938-941.
342. Harrigan MR Cerebral salt wasting syndrome: A review. Neurosurgery 1996, 38:152-160.
343. Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: Relationship to vasospasm and outcome. Neurology 2001, 22(56):1299-1304.
344. Neil-Dwyer G, Walter P, Shaw HJ, et al. Plasma renin activity in patients after a subarachnoid hemorrhage-a possible predictor of outcome. Neurosurgery 1980, 7:578-582.
345. Hindman BJ, Todd MM, Gelb AW, et al. Mild hypothermia as a protective therapy during intracranial aneurysm surgery: A randomized prospective pilot trial. Neurosurgery 1999, 44:23-32.
346. Khaldi A, Zauner A, Reinert M, et al. Measurement of nitric oxide and brain tissue oxygen tension in patients after severe subarachnoid hemorrhage. Neurosurgery 2001, 49:33-38.
347. Charbel FT, Du X, Hoffman WE, Ausman JI Brain tissue P o 2, P co 2, and pH during cerebral vasospasm. Surg Neurol 2000, 54:432-437.
348. Kiening KL, Unterberg AW, Bardt TF, et al. Monitoring of cerebral oxygenation in patients with severe head injuries: Brain tissue P o 2 versus jugular vein oxygen saturation. J Neurosurg 1996, 85:751-757.
349. Guglielmi G, Vinuela F, Duckwiler G, et al. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg 1992, 77:515-524.
350. Johnston SC, Wilson CB, Halbach VV, et al. Endovascular and surgical treatment of unruptured cerebral aneurysms: Comparison of risks. Ann Neurol 2000, 48:11-19.
351. Qureshi AI, Suri MF, Khan J, et al. Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: Safety and feasibility. J Neurosurg 2001, 94:880-885.
352. Cognard C, Weill A, Spelle L, et al. Long-term angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils. Radiology 1999, 212:348-356.
353. Vanninen R, Koivisto T, Saari T, et al. Ruptured intracranial aneurysms: Acute endovascular treatment with electrolytically detachable coils-a prospective randomized study. Radiology 1999, 211:325-336.
354. Casasco AE, Aymard A, Gobin YP, et al. Selective endovascular treatment of 71 intracranial aneurysms with platinum coils. J Neurosurg 1993, 79:3-10.
355. Brilstra EH, Rinkel GJ, van der Graaf Y, et al. Treatment of intracranial aneurysms by embolization with coils: A systematic review. Stroke 1999, 30:470-476.
356. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991, 338:597-600.
357. De Bruijn SFTM, Stam J Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999, 30:484-488.
358. Scott JA, Pascuzzi RM, Hall PV, Becker GJ Treatment of dural sinus thrombosis with local urokinase infusion: Case report. J Neurosurg 1988, 68:284-287.
359. Barnwell SL, Higashida RT, Halbach VV, et al. Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery 1991, 28:135-142.
360. Manthous CA, Chen H Case report: Treatment of superior sagittal sinus thrombosis with urokinase. Conn Med 1992, 56:529-530.
361. Tsai FY, Higashida RT, Matovich V, Alfieri K Acute thrombosis of the intracranial dural sinus: Direct thrombolytic treatment. AJNR Am J Neuroradiol 1992, 13:1137-1141.
362. Smith TP, Higashida RT, Barnwell SL, et al. Treatment of dural sinus thrombosis by urokinase infusion. AJNR Am J Neuroradiol 1994, 15:801-807.
363. Griesemer DA, Theodorou AA, Berg RA, Spera TD Local fibrinolysis in cerebral venous thrombosis. Pediatr Neurol 1994, 10:78-80.
364. Horowitz M, Purdy P, Unwin H, et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995, 38:58-67.
365. Gurley MB, King TS, Tsai FY Sigmoid sinus thrombosis associated with internal jugular venous occlusion: Direct thrombolytic treatment. J Endovasc Surg 1996, 3:306-314.
366. Spearman MP, Jungreis CA, Wehner JJ, et al. Endovascular thrombolysis in deep cerebral venous thrombosis. Am J Neuroradiol 1997, 18:502-506.
367. Gerszten PC, Welch WC, Spearman MP, et al. Isolated deep cerebral venous thrombosis treated by direct endovascular thrombolysis. Surg Neurol 1997, 48:261-266.
368. Smith AG, Cornblath WT, Deveikis JP Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology 1997, 48:1613-1619.
369. Holder CA, Bell DA, Lundell AL, et al. Isolated straight sinus and deep cerebral venous thrombosis: Successful treatment with local infusion of urokinase. Case report. J Neurosurg 1997, 86:704-707.
370. Rael JR, Orrison WW, Baldwin N, Sell J Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage. Am J Neuroradiol 1997, 18:1238-1242.
371. D'Alise MD, Fichtel F, Horrowitz M Sagittal sinus thrombosis following minor head injury treated with continuous urokinase infusion. Surg Neurol 1998, 49:430-435.
372. Kuether TA, O'Neill O, Nesbit GM, Barnwell SL Endovascular treatment of traumatic dural sinus thrombosis: Case report. Neurosurgery 1998, 42:1163-1166.
373. Kasner S, Gurian J, Grotta J Urokinase treatment of sagittal sinus thrombosis with venous hemorrhagic infarction. J Stroke Cerebrovasc Dis 1998, 7:421-425.
374. Philips MF, Bagley LJ, Sinson GP, et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999, 90:65-71.
375. Dowd CF, Malek AM, Phatouros CC, Hemphill JC Application of a rheolytic thrombectomy device in the treatment of dural sinus thrombosis: A new technique. Am J Neuroradiol 1999, 20:568-570.
376. Gomez CR, Misra VK, Terry JB, et al. Emergency endovascular treatment of cerebral sinus thrombosis with a rheolytic catheter device. J Neuroimaging 2000, 10:177-180.
377. Novak Z, Coldwell DM, Brega KE Selective infusion of urokinase and thrombectomy in the treatment of acute cerebral sinus thrombosis. Am J Neuroradiol 2000, 21:143-145.
378. Kim S, Suh J Direct endovascular thrombolytic therapy for dural sinus thrombosis: Infusion of alteplase. Am J Neuroradiol 1997, 18:639-645.
379. Frey JL, Muro GJ, McDougall CG, et al. Cerebral sinus thrombosis: Combined intrathrombus rtPA and intravenous heparin. Stroke 1999, 30:489-494.